Lederer & Associates Investment Counsel’s CVS Health CVS Stock Holding History

Lederer & Associates Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-400	Closed	-$30.1K	–	102
2021 Q1	$30.1K	Buy	+400	New	+$29.1K	0.02%	114
2018 Q1	–	Sell	-23,320	Closed	-$1.69M	–	92
2017 Q4	$1.69M	Sell	23,320 -725	-3%	-$52.7K	1.51%	31
2017 Q3	$1.96M	Buy	24,045 +165	+0.7%	+$13.1K	1.86%	20
2017 Q2	$1.92M	Buy	23,880 +390	+2%	+$30.8K	1.85%	22
2017 Q1	$1.84M	Sell	23,490 -475	-2%	-$37.9K	1.73%	23
2016 Q4	$1.89M	Buy	+23,965	New	+$1.94M	1.88%	20
2015 Q3	$2.81M	Buy	29,075 +1,215	+4%	+$128K	3.12%	3
2015 Q2	$2.92M	Buy	27,860 +575	+2%	+$58.7K	3%	3
2015 Q1	$2.82M	Sell	27,285 -1,130	-4%	-$114K	2.75%	3
2014 Q4	$2.74M	Buy	+28,415	New	+$2.5M	2.71%	3

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lederer & Associates Investment Counsel's CVS Position: Q2 2021 in Review

Lederer & Associates Investment Counsel sold out of CVS Health (CVS) in Q2 2021, closing a stake of 400 shares — an estimated $30.1K sold.

Lederer & Associates Investment Counsel first reported a position in CVS in Q4 2014 and held it in 10 quarters. The position peaked at $2.92M in Q2 2015. 2,065 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

Lederer & Associates Investment Counsel reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
Lederer & Associates Investment Counsel sold 400 CVS Health shares in Q2 2021, an estimated $30.1K.
Lederer & Associates Investment Counsel first reported a position in CVS Health in Q4 2014 and held it in 10 quarters.
Lederer & Associates Investment Counsel's CVS Health position peaked at $2.92M in Q2 2015.
2,065 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2021, filed 23 Jul 2021.